Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1408890

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1408890

Nucleic Acid Therapeutics CDMO Market, By Product Type, By Service, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

PUBLISHED:
PAGES: 269 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

Nucleic Acid Therapeutics CDMO Market size was valued at USD 11,756.3 Million in 2022, expanding at a CAGR of 10.3% from 2023 to 2030.

Nucleic acid Contract Development and Manufacturing Organizations (CDMOs) hold a critical position in the ever-changing realm of pharmaceutical advancements. Their specialized proficiency in developing, manufacturing, and producing nucleic acid-based therapeutics, such as mRNA, siRNA, gene therapies, and oligonucleotides, underscores their importance in turning innovative research into practical treatments.

Nucleic Acid Therapeutics CDMO Market- Market Dynamics

Advancements in nucleic acid therapeutics, intricate manufacturing procedures, and heightened investments to propel market demand

The market is primarily steered by advancements in nucleic acid therapeutics, intricate manufacturing procedures, and heightened investments. Additionally, the increasing regulatory approvals for nucleic acid therapeutics and the global rise in demand for personalized medicine are poised to drive the need for cost-effective CDMO services, consequently propelling market expansion. Nucleic acid treatments offer personalized healthcare by tailoring to an individual's genetic makeup. With the escalating demand for precision medicine and targeted therapies, these CDMOs emerge as vital partners for pharmaceutical and bioEnd User firms aiming to leverage the potential of nucleic acid-based medications.Their commitment to upholding rigorous quality standards, navigating through regulatory complexities, and employing state-of-the-art technologies facilitates efficient and scalable production of these intricate molecules. Consequently, this drives advancements and accessibility to transformative nucleic acid-based therapies, addressing a wide array of medical necessities.

Nucleic Acid Therapeutics CDMO Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.3% over the forecast period (2023-2030)
  • Based on product type segmentation, RNA-based therapies was predicted to show maximum market share in the year 2022
  • Based on Service segmentation, manufacturing services was the leading type in 2022
  • Based on Application segmentation, Oncology was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Nucleic Acid Therapeutics CDMO Market- Segmentation Analysis:

  • The Global Nucleic Acid Therapeutics CDMO Market is segmented on the basis of Product Type, Service, Application, End User, and Region.
  • The market is divided into two categories based on product type: Gene Therapy and RNA-based Therapies. In 2022, the RNA-based therapies sector emerged as the dominant force in the global market. ClinicalTrials.gov data revealed over 3,500 ongoing clinical trials involving RNA therapies for diverse diseases. Encouraging results from recent trials underscore the substantial potential of RNA-based medications in addressing various illnesses, anticipated to propel the growth of this segment.
  • The market is divided into four categories based on Service: Process Development and Optimization, Manufacturing Services, Analytical and Quality Control Services and Others. The manufacturing services category commanded a significant revenue share in 2022. Nucleic acid-based therapies, encompassing RNA and gene therapies, demand specialized knowledge and expertise in manufacturing. CDMOs exclusively focused on nucleic acid manufacturing have cultivated an in-depth understanding of these therapies, granting them a competitive edge. Within the nucleic acid therapeutics CDMO market, services are further segmented into process development and optimization, manufacturing services, analytical and quality control services, and others.

Nucleic Acid Therapeutics CDMO Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Nucleic Acid Therapeutics CDMO Market- Competitive Landscape:

Within the dynamic sphere of nucleic acid Contract Development and Manufacturing Organizations (CDMOs), companies navigate the industry strategically by adopting multifaceted approaches. These entities prioritize specialization by focusing efforts on mRNA, siRNA, gene editing, or oligonucleotide synthesis segments. By refining expertise in these specialized domains, CDMOs offer customized solutions and optimized services tailored to their clients' specific requirements. Concurrently, they emphasize substantial investments in state-of-the-art End User and infrastructure, ensuring their facilities are equipped with the latest advancements in nucleic acid manufacturing processes. Compliance remains a fundamental aspect of their operations, with stringent attention on meeting and exceeding regulatory standards set by bodies like the FDA or EMA. Moreover, flexibility and scalability are emphasized in their services, enabling adaptable manufacturing solutions accommodating diverse project sizes and specifications. This adaptability facilitates agility in response to the evolving needs of pharmaceutical and bioEnd User partners, consolidating their position in the competitive market.

Recent Developments:

In April 2023, Exothera collaborated with Quantoom Biosciences to leverage Quantoom's innovative Nfinity End User-a cutting-edge continuous production platform crafted for RNA. This partnership positions Exothera as the pioneering Contract Development and Manufacturing Organization (CDMO) globally to offer an off-the-shelf service for continuous RNA production, expanding its expertise in the RNA manufacturing domain.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS

  • Catalent
  • Thermo Fisher Scientific
  • Lonza
  • FUJIFILM Diosynth Biotechnologies
  • Cognate BioServices
  • Eurofins Genomics
  • Sirion Biotech
  • Oxford Biomedica
  • Danaher (Aldevron)
  • Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY PRODUCT TYPE

  • Gene Therapy
  • RNA-based Therapies

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY SERVICE

  • Process Development and Optimization
  • Manufacturing Services
  • Analytical and Quality Control Services
  • Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION

  • Oncology
  • Genetic Disorders
  • Infectious Diseases
  • Others

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END USER

  • Pharmaceutical Companies
  • Government & Academic Research Institutes
  • Biotech Companies

GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Product Code: ANV2052

Table of Contents

1. Nucleic Acid Therapeutics CDMO Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nucleic Acid Therapeutics CDMO Market Snippet by Product Type
    • 2.1.2. Nucleic Acid Therapeutics CDMO Market Snippet by Service
    • 2.1.3. Nucleic Acid Therapeutics CDMO Market Snippet by Application
    • 2.1.4. Nucleic Acid Therapeutics CDMO Market Snippet by End User
    • 2.1.5. Nucleic Acid Therapeutics CDMO Market Snippet by Country
    • 2.1.6. Nucleic Acid Therapeutics CDMO Market Snippet by Region
  • 2.2. Competitive Insights

3. Nucleic Acid Therapeutics CDMO Key Market Trends

  • 3.1. Nucleic Acid Therapeutics CDMO Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nucleic Acid Therapeutics CDMO Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nucleic Acid Therapeutics CDMO Market Opportunities
  • 3.4. Nucleic Acid Therapeutics CDMO Market Future Trends

4. Nucleic Acid Therapeutics CDMO Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nucleic Acid Therapeutics CDMO Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Nucleic Acid Therapeutics CDMO Market Landscape

  • 6.1. Nucleic Acid Therapeutics CDMO Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nucleic Acid Therapeutics CDMO Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Gene Therapy
    • 7.1.3. RNA-based Therapies

8. Nucleic Acid Therapeutics CDMO Market - By Service

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Service, 2022 & 2030 (%)
    • 8.1.2. Process Development and Optimization
    • 8.1.3. Manufacturing Services
    • 8.1.4. Analytical and Quality Control Services
    • 8.1.5. Others

9. Nucleic Acid Therapeutics CDMO Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Oncology
    • 9.1.3. Genetic Disorders
    • 9.1.4. Infectious Diseases
    • 9.1.5. Others

10. Nucleic Acid Therapeutics CDMO Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Government & Academic Research Institutes
    • 10.1.4. Biotech Companies

11. Nucleic Acid Therapeutics CDMO Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Service, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Nucleic Acid Therapeutics CDMO Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Catalent
    • 12.2.2. Thermo Fisher Scientific
    • 12.2.3. Lonza
    • 12.2.4. FUJIFILM Diosynth Biotechnologies
    • 12.2.5. Cognate BioServices
    • 12.2.6. Eurofins Genomics
    • 12.2.7. Sirion Biotech
    • 12.2.8. Oxford Biomedica
    • 12.2.9. Danaher (Aldevron)
    • 12.2.10. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
Product Code: ANV2052

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nucleic Acid Therapeutics CDMO Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Product Type 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: Service Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Service
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Service 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Application 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by End User 2018-2030 (USD Million)
  • TABLE Nucleic Acid Therapeutics CDMO Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nucleic Acid Therapeutics CDMO Market, by Region 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Service, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nucleic Acid Therapeutics CDMO Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Nucleic Acid Therapeutics CDMO Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Service segment market share analysis, 2022 & 2030
  • FIGURE Service segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Europe Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Asia Pacific Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Latin America Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE Middle East and Africa Nucleic Acid Therapeutics CDMO Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE Germany Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE India Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE Brazil Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nucleic Acid Therapeutics CDMO Market share analysis by country, 2022
  • FIGURE Saudi Arabia Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Nucleic Acid Therapeutics CDMO Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!